2seventy Bio, Inc. (TSVT)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about 2seventy Bio, Inc. (TSVT)
Go deeper and ask any question about TSVT
Company Performance
Current Price
as of Sep 13, 2024$4.71
P/E Ratio
N/A
Market Cap
$242.56M
Description
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.
Metrics
Overview
- HQCambridge, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerTSVT
- Price$4.71+2.61%
Trading Information
- Market Cap$242.56M
- Float93.62%
- Average Daily Volume (1m)249,064
- Average Daily Volume (3m)409,561
- EPS-$3.04
Company
- Revenue$44.12M
- Rev Growth (1yr)-75.12%
- Net Income$24.88M
- Gross Margin42.80%
- EBITDA Margin-208.32%
- EBITDA-$18.68M
- EV$261.31M
- EV/Revenue5.92
- P/EN/A
- P/S5.87
Documents
SEC Filings
Factset Street Account
Factset